The National Cancer Institute is offering a grant opportunity focusing on advancing and validating innovative technologies for cancer-related biospecimen research. This grant aims to address pre-analytical variations in biospecimen handling, enhancing sample quality for downstream analyses. Projects must demonstrate proof-of-principle technology with preliminary data available. The objectives include developing tools, instrumentation, and methods to evaluate sample quality, maintain sample integrity, and establish quality control criteria under various conditions. Applications involving established technologies focused on new clinical or biological questions are not suitable for this opportunity. Closing date for submissions is September 20, 2013.
Opportunity ID: 206216
General Information
| Document Type:: | Grants Notice |
| Funding Opportunity Number:: | RFA-CA-13-004 |
| Funding Opportunity Title:: | Validation and Advanced Development of Emerging Technologies for Biospecimen Science (R33) |
| Opportunity Category:: | Discretionary |
| Opportunity Category Explanation:: | |
| Funding Instrument Type:: | |
| Category of Funding Activity:: | Education |
| Category Explanation:: | |
| Expected Number of Awards:: | 2 |
| Assistance Listings Number(s):: | 93.393 — Cancer Cause and Prevention Research |
| Cost Sharing or Matching Requirement:: | No |
| Version:: | Synopsis 1 |
| Posted Date:: | Nov 09, 2012 |
| Last Updated Date:: | |
| Original Closing Date for Applications:: | Sep 20, 2013 |
| Current Closing Date for Applications:: | Sep 20, 2013 |
| Archive Date:: | Oct 21, 2013 |
| Estimated Total Program Funding:: | $ 700,000 |
| Award Ceiling:: | $300,000 |
| Award Floor:: | $ |
Eligibility
| Eligible Applicants:: | Public housing authorities/Indian housing authorities |
| Additional Information on Eligibility:: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession; Non-domestic (non-U.S.) Entities (Foreign Institutions) are eligible to apply. Non-domestic (non-U.S.) components of U.S. Organizations are eligible to apply. Foreign components, as defined in the NIH Grants Policy Statement, are allowed |
Additional Information
| Agency Name:: | National Institutes of Health |
| Description:: | This Funding Opportunity Announcement (FOA), issued by the National Cancer Institute (NCI), solicits grant applications proposing technically innovative feasibility studies focused on the advanced development and validation of cancer-relevant technologies that address issues related to pre-analytical variations in the collection, processing, handling, and storage of biospecimens or their derivatives. The overall goal is to develop technologies capable of interrogating and/or maximizing the quality and utility of biospecimens or their derived samples for downstream analyses. This FOA will support the development of tools, devices, instrumentation, and associated methods to assess sample quality, preserve/protect sample integrity, and establish verification criteria for quality assessment/quality control and handling under diverse conditions. This FOA solicits R33 applications; this mechanism is suitable for projects where proof-of-principle of the proposed technology or methodology has already been established and supportive preliminary data are available. Projects proposing to use established technologies where the novelty resides in the biological or clinical question being pursued are an example of a topic not appropriate for this solicitation as non-responsive and will not be reviewed. |
| Link to Additional Information:: | |
| Grantor Contact Information:: | If you have difficulty accessing the full announcement electronically, please contact: |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Synopsis 1 |
Package Status
Below are CLOSED Opportunity Package(s) no longer available for this Funding Opportunity:
Package No: 1
| Assistance Listings: | |
| Competition ID: | ADOBE-FORMS-B2 |
| Competition Title: | Adobe-Forms-B2 |
| Opportunity Package ID: | PKG00151430 |
| Opening Date: | Jan 20, 2013 |
| Closing Date: | Sep 20, 2013 |
| Agency Contact Information:: | eRA Commons Help Desk |
| Who Can Apply:: | Organization Applicants |
| mendatory_forms |
SF424 (R & R) [V1.2] Project/Performance Site Location(s) [V1.4] Research And Related Other Project Information [V1.3] Research And Related Senior/Key Person Profile (Expanded) [V1.2] Research & Related Budget [V1.1] PHS 398 Cover Page Supplement [V1.4] PHS 398 Research Plan [V1.3] PHS 398 Checklist [V1.3] |
| optional_forms |
R & R Subaward Budget Attachment(s) Form 5 YR 30 ATT [V1.2] PHS Cover Letter [V1.2] |
Packages
| Assistance Listings | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions | Who Can Apply: | |
|---|---|---|---|---|---|---|---|---|
| ADOBE-FORMS-B2 | Adobe-Forms-B2 | PKG00151430 | Jan 20, 2013 | Sep 20, 2013 | View | eRA Commons Help Desk | Organization Applicants |